These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 14698200)
21. Synthesis and characterization of [¹²⁵I]2-iodo N-[(S)-{(S)-1-methylpiperidin-2-yl}(phenyl)methyl]3-trifluoromethyl-benzamide as novel imaging probe for glycine transporter 1. Fuchigami T; Haratake M; Magata Y; Haradahira T; Nakayama M Bioorg Med Chem; 2011 Nov; 19(21):6245-53. PubMed ID: 21975065 [TBL] [Abstract][Full Text] [Related]
22. Blockade of the GlyT1 glycine transporter prolongs response to VTA stimulation in nucleus accumbens neurons. Lewis B; O'Donnell P Ann N Y Acad Sci; 2003 Nov; 1003():431-4. PubMed ID: 14684480 [No Abstract] [Full Text] [Related]
23. The glycine neurotransmitter transporter GLYT1 is an organic osmolyte transporter regulating cell volume in cleavage-stage embryos. Steeves CL; Hammer MA; Walker GB; Rae D; Stewart NA; Baltz JM Proc Natl Acad Sci U S A; 2003 Nov; 100(24):13982-7. PubMed ID: 14615585 [TBL] [Abstract][Full Text] [Related]
24. 5,5-Diaryl-2-amino-4-pentenoates as novel, potent, and selective glycine transporter type-2 reuptake inhibitors. Isaac M; Slassi A; Silva KD; Arora J; MacLean N; Hung B; McCallum K Bioorg Med Chem Lett; 2001 Jun; 11(11):1371-3. PubMed ID: 11378357 [TBL] [Abstract][Full Text] [Related]
25. Development of a novel high-throughput assay for the investigation of GlyT-1b neurotransmitter transporter function. Allan L; Leith JL; Papakosta M; Morrow JA; Irving NG; McFerran BW; Clark AG Comb Chem High Throughput Screen; 2006 Jan; 9(1):9-14. PubMed ID: 16454681 [TBL] [Abstract][Full Text] [Related]
26. Screening for New Inhibitors of Glycine Transporter 1 and 2 by Means of MS Binding Assays. Ackermann TM; Höfner G; Wanner KT ChemMedChem; 2021 Oct; 16(19):3094-3104. PubMed ID: 34174033 [TBL] [Abstract][Full Text] [Related]
27. 2-Chloro-N-[(S)-phenyl [(2S)-piperidin-2-yl] methyl]-3-trifluoromethyl benzamide, monohydrochloride, an inhibitor of the glycine transporter type 1, increases evoked-dopamine release in the rat nucleus accumbens in vivo via an enhanced glutamatergic neurotransmission. Leonetti M; Desvignes C; Bougault I; Souilhac J; Oury-Donat F; Steinberg R Neuroscience; 2006; 137(2):555-64. PubMed ID: 16289893 [TBL] [Abstract][Full Text] [Related]
28. [3H]-(R)-NPTS, a radioligand for the type 1 glycine transporter. Lowe JA; Drozda SE; Fisher K; Strick C; Lebel L; Schmidt C; Hiller D; Zandi KS Bioorg Med Chem Lett; 2003 Apr; 13(7):1291-2. PubMed ID: 12657266 [TBL] [Abstract][Full Text] [Related]
29. Synthesis and SAR of GlyT1 inhibitors derived from a series of N-((4-(morpholine-4-carbonyl)-1-(propylsulfonyl)piperidin-4-yl)methyl)benzamides. Zhao Z; O'Brien JA; Lemaire W; Williams DL; Jacobson MA; Sur C; Pettibone DJ; Tiller PR; Smith S; Hartman GD; Wolkenberg SE; Lindsley CW Bioorg Med Chem Lett; 2006 Dec; 16(23):5968-72. PubMed ID: 16987662 [TBL] [Abstract][Full Text] [Related]
30. Modulation of striatal dopamine release by glycine transport inhibitors. Javitt DC; Hashim A; Sershen H Neuropsychopharmacology; 2005 Apr; 30(4):649-56. PubMed ID: 15688094 [TBL] [Abstract][Full Text] [Related]
31. The therapeutic potential of glycine transporter-1 inhibitors. Sur C; Kinney GG Expert Opin Investig Drugs; 2004 May; 13(5):515-21. PubMed ID: 15155126 [TBL] [Abstract][Full Text] [Related]
32. Effects of typical and atypical antipsychotics on human glycine transporters. Williams JB; Mallorga PJ; Conn PJ; Pettibone DJ; Sur C Schizophr Res; 2004 Nov; 71(1):103-12. PubMed ID: 15374578 [TBL] [Abstract][Full Text] [Related]
34. Amino-terminal isoforms of the human glycine transporter GlyT1 exhibit similar pharmacology. Durkin JT; Spais CM; Schreiber J; Kopec K; Meyer SL Brain Res; 2011 Feb; 1374():1-7. PubMed ID: 21138739 [TBL] [Abstract][Full Text] [Related]
35. Arachidonic acid and anandamide have opposite modulatory actions at the glycine transporter, GLYT1a. Pearlman RJ; Aubrey KR; Vandenberg RJ J Neurochem; 2003 Feb; 84(3):592-601. PubMed ID: 12558979 [TBL] [Abstract][Full Text] [Related]
36. Glycine transporter type 1 blockade changes NMDA receptor-mediated responses and LTP in hippocampal CA1 pyramidal cells by altering extracellular glycine levels. Martina M; Gorfinkel Y; Halman S; Lowe JA; Periyalwar P; Schmidt CJ; Bergeron R J Physiol; 2004 Jun; 557(Pt 2):489-500. PubMed ID: 15064326 [TBL] [Abstract][Full Text] [Related]
37. Identification of novel inhibitors of the amino acid transporter B Cheng Q; Shah N; Bröer A; Fairweather S; Jiang Y; Schmoll D; Corry B; Bröer S Br J Pharmacol; 2017 Mar; 174(6):468-482. PubMed ID: 28176326 [TBL] [Abstract][Full Text] [Related]
38. Validation of a fluorescent imaging plate reader membrane potential assay for high-throughput screening of glycine transporter modulators. Benjamin ER; Skelton J; Hanway D; Olanrewaju S; Pruthi F; Ilyin VI; Lavery D; Victory SF; Valenzano KJ J Biomol Screen; 2005 Jun; 10(4):365-73. PubMed ID: 15964938 [TBL] [Abstract][Full Text] [Related]
39. The neuronal glycine transporter 2 interacts with the PDZ domain protein syntenin-1. Ohno K; Koroll M; El Far O; Scholze P; Gomeza J; Betz H Mol Cell Neurosci; 2004 Aug; 26(4):518-29. PubMed ID: 15276154 [TBL] [Abstract][Full Text] [Related]
40. Discovery and SAR of org 24598-a selective glycine uptake inhibitor. Brown A; Carlyle I; Clark J; Hamilton W; Gibson S; McGarry G; McEachen S; Rae D; Thorn S; Walker G Bioorg Med Chem Lett; 2001 Aug; 11(15):2007-9. PubMed ID: 11454468 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]